Thursday, June 11

Browsing: serous

Support

Avutometinib/Defactinib Yields Responses in Low-Grade Serous Ovarian Cancer

By NewsCancerApril 11, 20260

The combination of avutometinib and defactinib (Avmapki Fakzynja Co-pack) continued to demonstrate durable efficacy and an acceptable safety profile in…

Research

Pre-operative circulating tumor cells predict worse treatment outcome in patients with high-grade serous ovarian cancer

By NewsCancerApril 5, 20260

Huang J, Chan WC, Ngai CH, Lok V, Zhang L, Lucero-Prisno DE 3rd, et al. Worldwide burden, risk factors, and…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Scientists shut down cancer DNA repair to overcome drug resistance

The future is not always uniform: rethinking radiotherapy through spatial fractionation

CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor–stromal signaling

Browsing: serous

Avutometinib/Defactinib Yields Responses in Low-Grade Serous Ovarian Cancer

Pre-operative circulating tumor cells predict worse treatment outcome in patients with high-grade serous ovarian cancer

Scientists shut down cancer DNA repair to overcome drug resistance

The future is not always uniform: rethinking radiotherapy through spatial fractionation

CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor–stromal signaling

76 Real-World Safety of Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Insights From US Community Oncology Practices

Scientists shut down cancer DNA repair to overcome drug resistance

The future is not always uniform: rethinking radiotherapy through spatial fractionation

CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor–stromal signaling

76 Real-World Safety of Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Insights From US Community Oncology Practices

Latest Post

Scientists shut down cancer DNA repair to overcome drug resistance

The future is not always uniform: rethinking radiotherapy through spatial fractionation

CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor–stromal signaling

Subscribe to Updates

What's Hot

Browsing: serous